Drug ‘significantly’ slows Alzheimer’s progression: Study A clinical trial of donanemab has now been peer reviewed and published, indicating it can decelerate decline in the disease’s early stages.
Bowel cancer screening rates down Though participation in screening has dropped, wait times for colonoscopy referrals are in excess of the recommended 30-day timeframe.
TGA’s vaping crackdown a sign of things to come The medicines regulator issued infringement notices to four entities this week, totalling almost $600,000.
Does multimorbidity impact chronic disease treatment? New international research has looked into a range of chronic diseases and their potential impact on effectiveness of common medications.
RACGP moves to shore up wavering support for 60-day dispensing Amid reports of crossbenchers becoming wary of the reform, the college has co-signed an open letter outlining the expected benefits for both patients and the primary care system.
‘Historic’ funding changes for opioid dependency treatment Addiction GPs say the changes will help to reduce barriers when it comes to prescribing and access – and in the process reduce stigma.
Trial highlights lack of awareness on alcohol and breast cancer link But an Australian study looking at the effectiveness of alcohol intervention targeting women has shown promise for change.
‘Duty of care’ to help Close the Gap: RACGP leaders The college hosted a webinar to mark National Reconciliation Week and explore this year’s theme: ‘Be a Voice for Generations’.
Bowel cancer incidence rates up 266% among 15–24-year-olds Research has found age bias as a perceived barrier to getting a diagnosis for the deadly cancer – but a GP expert says there are other factors.
Insurance cut for gender-affirming care ‘sends such a negative signal’ MDA National will no longer cover GPs initiating gender-affirming treatment for adolescents – a move that could impact patient wellbeing.